Ronald van Vollenhoven
Amsterdam University Medical Centers(NL)
Publications by Year
Research Areas
Systemic Lupus Erythematosus Research, Rheumatoid Arthritis Research and Therapies, Monoclonal and Polyclonal Antibodies Research, Chronic Lymphocytic Leukemia Research, Autoimmune and Inflammatory Disorders Research
Most-Cited Works
- → EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update(2017)5,757 cited
- → Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus(2012)5,182 cited
- → EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update(2020)2,708 cited
- → 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus(2019)1,964 cited
- → The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment(2005)1,780 cited
- → A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus